An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain.

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

Sleep disturbances may accelerate neurodegeneration, but whether they cause or result from disease remains unclear. Improving ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

You might not remember what you ate for breakfast yesterday, but your body certainly does. For better or worse, your dietary ...

New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease. Research indicates amyloid beta plaques, sticky clumps of protein that ...

Not the Same. In amyloid-negative people (left) few tangles accumulate over a decade. In amyloid-positives (right), tangles grow faster in women (red) than men (blue). [Courtesy of Gillian Coughlan, ...